Osurdex is developed by Maturi, Raj K., M.D., P.C..

What development phase is Osurdex in?

Osurdex is FDA-approved (marketed).

Last reviewed 2026-04-19 · How we verify

Osurdex

Maturi, Raj K., M.D., P.C. · FDA-approved active Small molecule

At a glance

Generic name	Osurdex
Sponsor	Maturi, Raj K., M.D., P.C.
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Osurdex CI brief — competitive landscape report
Osurdex updates RSS · CI watch RSS
Maturi, Raj K., M.D., P.C. portfolio CI